Lifecore Biomedical Inc. (LFCR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Lifecore Biomedical Inc. (LFCR) has a cash flow conversion efficiency ratio of -0.136x as of May 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.19 Million) by net assets ($16.09 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Lifecore Biomedical Inc. for the company's overall valuation and market capitalisation.
Lifecore Biomedical Inc. - Cash Flow Conversion Efficiency Trend (1996–2026)
This chart illustrates how Lifecore Biomedical Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Lifecore Biomedical Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lifecore Biomedical Inc. ranked by their cash flow conversion efficiency. Explore Lifecore Biomedical Inc. earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Daeho Al Co. Ltd.
KO:069460
|
0.081x |
|
Sparebanken Ost
OL:SPOG
|
0.022x |
|
1911 Gold Corp
V:AUMB
|
-0.121x |
|
Scottie Resources Corp
V:SCOT
|
-1.010x |
|
Sang-A Frontec Co.Ltd
KQ:089980
|
0.080x |
|
Valens
NYSE:VLN
|
-0.043x |
|
Jyong Biotech Ltd. Ordinary Shares
NASDAQ:MENS
|
0.037x |
|
Tianjin Capital Environmental Protection Group Company Limited
F:TIA
|
0.070x |
Annual Cash Flow Conversion Efficiency for Lifecore Biomedical Inc. (1996–2026)
The table below shows the annual cash flow conversion efficiency of Lifecore Biomedical Inc. from 1996 to 2026. View Lifecore Biomedical Inc. share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-05-31 | $-14.20 Million | $12.57 Million | -0.885x | -473.82% |
| 2025-05-31 | $1.34 Million | $-206.00K | -0.154x | -778.86% |
| 2024-05-31 | $11.31 Million | $257.00K | 0.023x | +108.83% |
| 2023-05-31 | $87.82 Million | $-22.59 Million | -0.257x | -13.81% |
| 2022-05-31 | $107.94 Million | $-24.40 Million | -0.226x | -378.28% |
| 2021-05-31 | $202.78 Million | $16.47 Million | 0.081x | +210.12% |
| 2020-05-31 | $231.04 Million | $-17.04 Million | -0.074x | -224.38% |
| 2019-05-31 | $270.14 Million | $16.02 Million | 0.059x | -24.28% |
| 2018-05-31 | $252.56 Million | $19.78 Million | 0.078x | -39.08% |
| 2017-05-31 | $228.15 Million | $29.33 Million | 0.129x | +25.30% |
| 2016-05-31 | $212.35 Million | $21.78 Million | 0.103x | -13.67% |
| 2015-05-31 | $220.11 Million | $26.16 Million | 0.119x | +15.62% |
| 2014-05-31 | $204.76 Million | $21.05 Million | 0.103x | -12.66% |
| 2013-05-31 | $180.41 Million | $21.23 Million | 0.118x | -19.60% |
| 2012-05-31 | $151.56 Million | $22.18 Million | 0.146x | +39.31% |
| 2011-05-31 | $137.73 Million | $14.47 Million | 0.105x | +85.99% |
| 2010-05-31 | $132.47 Million | $7.48 Million | 0.056x | -23.85% |
| 2009-05-31 | $127.20 Million | $9.44 Million | 0.074x | -50.88% |
| 2008-05-31 | $116.02 Million | $17.52 Million | 0.151x | +920.78% |
| 2007-05-31 | $112.07 Million | $-2.06 Million | -0.018x | -114.70% |
| 2006-05-31 | $86.82 Million | $10.87 Million | 0.125x | -29.48% |
| 2005-05-31 | $73.53 Million | $13.05 Million | 0.177x | +41.16% |
| 2004-05-31 | $63.10 Million | $7.93 Million | 0.126x | +7262.63% |
| 2002-05-31 | $57.54 Million | $-101.00K | -0.002x | +98.82% |
| 2001-05-31 | $50.87 Million | $-7.57 Million | -0.149x | -269.33% |
| 2000-05-31 | $57.00 Million | $5.01 Million | 0.088x | +177.61% |
| 1999-05-31 | $31.80 Million | $-3.60 Million | -0.113x | -12.21% |
| 1998-05-31 | $33.70 Million | $-3.40 Million | -0.101x | +34.70% |
| 1997-05-31 | $35.60 Million | $-5.50 Million | -0.154x | -57.07% |
| 1996-05-31 | $36.60 Million | $-3.60 Million | -0.098x | -- |
About Lifecore Biomedical Inc.
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device … Read more